๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Using gene co-expression network analysis to predict biomarkers for chronic lymphocytic leukemia

โœ Scribed by Jie Zhang; Yang Xiang; Liya Ding; Kristin Keen-Circle; Tara B Borlawsky; Hatice Gulcin Ozer; Ruoming Jin; Philip Payne; Kun Huang

Book ID
114999506
Publisher
BioMed Central
Year
2010
Tongue
English
Weight
795 KB
Volume
11
Category
Article
ISSN
1471-2105

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Use of IGHJ and IGHD gene mutations in a
Use of IGHJ and IGHD gene mutations in analysis of immunoglobulin sequences for the prognosis of chronic lymphocytic leukemia
โœ Cindy E.H. Lee; Katherine J.L. Jackson; William A. Sewell; Andrew M. Collins ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 120 KB

The level of somatic point mutation in immunoglobulin genes is an important prognostic indicator for patients with chronic lymphocytic leukemia (CLL). Mutation analysis presently focuses solely upon the heavy chain IGHV gene, however mutation is a stochastic process that also targets IGHD and IGHJ g

Comparative gene expression analysis of
Comparative gene expression analysis of a chronic myelogenous leukemia cell line resistant to cyclophosphamide using oligonucleotide arrays and response to tyrosine kinase inhibitors
โœ Fei Bao; Paula Polk; Mary L. Nordberg; Diana M. Veillon; Amanda Sun; Michael Dei ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 471 KB

Acquired imatinib resistance in chronic myelogenous leukemia (CML) can be the consequence of mutations in the kinase domain of BCR-ABL or increased protein levels. However, as in other malignancies, acquired resistance to cytostatic drugs is a common reason for treatment failure or disease progressi